Therapeutic efficacy of INX-315, a selective CDK2 inhibitor, in solid tumors [OVCAR3 RNAseq]
收藏NIAID Data Ecosystem2026-05-01 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP460314
下载链接
链接失效反馈官方服务：
资源简介：
We performed RNA sequencing on OVCAR3 parental cells treated with either control vehicle for 4 days or 300 nM INX-315 for 7 days. Overall design: OVCAR3 parental cells were treated with either control DMSO for 4 days or 300 nM INX-315 for 7 days. 3 replicates per group were collected.
创建时间：
2024-02-22
